Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma

Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma

Conditions: Thyroid Cancer
Interventions: Radiation: 131 I-iodine (131-I), 124 I-iodine (124-I)
Sponsors: Memorial Sloan Kettering Cancer Center; Gustave Roussy, Cancer Campus, Grand Paris
Active, not **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

September 30, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments